DIS announces its strategic collaboration with Lavipharm for the implementation of a comprehensive Microsoft Dynamics 365 Finance & Supply Chain Management project, as part of the broader digital transformation of the company’s business operations.
The implementation of Microsoft Dynamics 365 Finance & Supply Chain Management constitutes a key step toward the modernization of Lavipharm’s supply chain, leveraging advanced cloud ERP technologies to interconnect critical business processes.
Integrated Cloud Platform for the Supply Chain
The project is based on Microsoft Dynamics 365 Finance & Supply Chain Management and covers key functional areas:
- Finance
- Warehouse Management (WMS)
- Planning
- Production
- Procurement
- Sales
- Quality Control
The new ERP solution for the pharmaceutical sector aims to create a unified, cloud-based supply chain, fully aligned with the market’s strict regulatory requirements and designed to support the company’s international growth.
Lavipharm on a path of continuous growth
With a history of 115 years, Lavipharm is one of the strongest Greek pharmaceutical organizations, active in the research, development, production, and distribution of prescription and non-prescription pharmaceutical products.
The company holds strong expertise in Transdermal Drug Delivery Systems and operates a privately owned production facility of 8,000 sq.m. in Paiania, Attica. At the same time, it is active in markets across Europe, America, and Asia, strengthening its international presence.
Listed on the Athens Stock Exchange since 1995, Lavipharm consistently confirms its steady growth trajectory, strategically investing in the digital transformation of its business operations.
Business Benefits of the Microsoft Dynamics 365 Implementation
The utilization of Microsoft Dynamics 365 F&SCM will enable Lavipharm to achieve:
- End-to-end visibility of inventory, production, and quality in real time
- Full batch traceability from raw material to final product
- Strengthened regulatory compliance (GMP / GDP) and reduced operational risk through embedded Quality Control, Lot Release, and Quality Certificates’ Digital Signatures processes
- Supply chain optimization through unified Planning, Production, and WMS processes
- Rich and detailed reporting across all business activities
- Utilization of Artificial Intelligence capabilities for improved business decision-making
Collaboration Statements
Panos Kyriakopoulos, President & CEO of DIS, stated:
“Our collaboration with Lavipharm represents a flagship project for the digital transformation of the pharmaceutical supply chain and confirms our strategic focus on high business value projects with Microsoft Dynamics 365 Finance & Operations.”
Panagiotis Giannouleas, Deputy CEO of Lavipharm, stated:
“Lavipharm’s digital transformation constitutes a strategic investment for the company’s future, as well as for the way we operate and grow internationally. The implementation of Microsoft Dynamics 365 Finance & Supply Chain Management with DIS represents a pivotal step, as it will substantially enhance our operational efficiency across the entire supply chain.”
Strategic Digital Transformation Partnership
This collaboration further strengthens DIS’s position as a strategic digital transformation partner and Microsoft Dynamics 365 ERP implementation provider for high-demand organizations in the pharmaceutical and industrial sectors.
